Diagnos Laboratorium Utama PT Tbk (DGNS) — Cash Flow-to-Debt Ratio
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of Rp1.52 Billion could theoretically repay 0% of its total liabilities (Rp110.07 Billion) in one year. See financial agility of Diagnos Laboratorium Utama PT Tbk to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Diagnos Laboratorium Utama PT Tbk Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Diagnos Laboratorium Utama PT Tbk across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Diagnos Laboratorium Utama PT Tbk.
Annual Cash Flow-to-Debt Ratio for Diagnos Laboratorium Utama PT Tbk (2017–2024)
Year-by-year debt coverage analysis for Diagnos Laboratorium Utama PT Tbk. Check Diagnos Laboratorium Utama PT Tbk cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (IDR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | Rp27.30 Billion | Rp103.89 Billion | ▲ +51.2% |
| 2023 | 0.17x | Rp13.18 Billion | Rp75.88 Billion | ▲ +185.2% |
| 2022 | -0.20x | Rp-6.02 Billion | Rp29.51 Billion | ▼ -113.9% |
| 2021 | 1.47x | Rp58.87 Billion | Rp40.18 Billion | ▲ +87.2% |
| 2020 | 0.78x | Rp26.23 Billion | Rp33.51 Billion | ▼ -10.8% |
| 2019 | 0.88x | Rp11.20 Billion | Rp12.76 Billion | ▲ +15.7% |
| 2018 | 0.76x | Rp8.47 Billion | Rp11.17 Billion | ▲ +661.0% |
| 2017 | -0.14x | Rp-712.00 Million | Rp5.27 Billion | — |